Trial Profile
Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Neurofibromatosis 2
- Focus Therapeutic Use
- 17 Dec 2018 New trial record